Hemab ApS: Financial statements 2022
CVR: 40837590
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Hemab ApS (CVR 40837590) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -156,407,000 compared with DKK -35,163,000 the year before. Equity in the 2022 report amounted to DKK 6,101,000. The solvency ratio was 18.5%. The company had 10 employees in the financial year.
- Profit/Loss
- DKK -156,407,000
- Equity
- DKK 6,101,000
- Total Assets
- DKK 32,916,000
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -156.4 mio. | 6.1 mio. | 10 |
| 2021 | - | - | -35.2 mio. | 68 mio. | 3 |
Official annual report
Keep an eye on Hemab ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Hemab ApS has published its annual report for 2021. The net result was DKK -35,163,000.
As of January 10, 2022, Jørgen Søberg Petersen has joined the board of directors of Hemab ApS.
As of January 10, 2022, Linda Catharina Bain has joined the board of directors of Hemab ApS.
As of January 10, 2022, John Michael Maraganore has joined the board of directors of Hemab ApS.
As of January 10, 2022, Benny Sørensen is registered as adm. dir. of Hemab ApS.
As of January 9, 2022, Jørgen Søberg Petersen has left the board of directors of Hemab ApS.
About Hemab ApS
Hemab ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Ebumab Hemophilia ApS. The management consists of Benny Sørensen and Mads Nikolaj Behrndt-Eriksen. The board consists of John Michael Maraganore (chair), Akshay Krishnadas Vaishnaw, Benny Sørensen and Linda Catharina Bain. The company is owned by Hemab Therapeutics Holdings, Inc.. According to the 2025 annual report, the company had an average of 54 employees. Equity in the 2025 report amounted to USD 196,000.